AI deregulation shifts risk to private sector, Harvard Ethics Center's Boundaries of Tolerance Framework finds

What happened

Why it matters

• ·The deliberate reduction of federal AI oversight under the US AI Action Plan creates regulatory exposure for organizations that have relied on anticipated federal standards to anchor their governance programs, leaving them without a clear external compliance benchmark.
• ·Organizations in financial services, healthcare, and other regulated industries must now reconcile voluntary frameworks like the Boundaries of Tolerance Framework with existing sector-specific obligations from regulators such as the OCC, CFPB, and HHS, increasing operational complexity.
• ·Companies outside regulated sectors face heightened organizational risk because documented risk tolerance policies may face scrutiny from investors, auditors, or future regulators, and the absence of formalized internal governance documentation could be treated as a governance failure.

Governance controls affected

What to do now

• ☐Conduct a gap assessment of existing AI governance documentation to determine whether it is sufficient to demonstrate defensible risk management decisions in the absence of binding federal requirements.
• ☐Map the Boundaries of Tolerance Framework against sector-specific regulatory obligations under the OCC, CFPB, or HHS to identify conflicts or coverage gaps for regulated-industry deployments.
• ☐Draft or update formal risk tolerance policies that define acceptable risk ranges for AI development and deployment, treating these documents as audit-ready governance instruments.
• ☐Brief executive leadership and board-level risk committees on the implications of the US AI Action Plan deregulatory shift and the increased governance burden now placed on the private sector.
• ☐Establish a monitoring process to track how investors, auditors, and sector-specific regulators are interpreting voluntary AI governance frameworks as proxies for compliance standards.

What to watch next

Compliance teams should monitor whether US sector-specific regulators such as the OCC, CFPB, and HHS issue formal guidance clarifying how voluntary frameworks like the Boundaries of Tolerance Framework interact with existing supervisory expectations for AI risk management. Enforcement actions or supervisory letters from these agencies referencing internal risk documentation standards would signal that self-governance materials are being treated as de facto compliance instruments. Teams should also track developments in the EU AI Act implementation timeline, as the contrast between binding EU requirements and the US deregulatory posture may create divergent compliance obligations for multinational organizations.